The effects of intravitreal adalimumab injection on pseudophakic macular edema

BMC Research Notes

Table 1 Demographic characteristics, CMT, and BCVA of study patients

Patient No	Eye	Sex	BCVA1	BCVA2	BCVA3	CMT1	CMT2	CMT3
1	OD	Female	0.52	0.52	0.52	464	505	356
2	OD	Female	0.52	0.52	0.69	567	371	492 (422)
3	OS	Male	1.77	1.77	1.77	968	410	394
4	OD	Male	1.00	0.69	1.00	406	385 (413)	423
5	OD	Female	0.69	0.69	–	512	571	–

BCVA1 the logarithm of the minimum angle of resolution BCVA 1 day before injection, BCVA2 the logarithm of the minimum angle of resolution BCVA 1 week after injection; BCVA3 the logarithm of the minimum angle of resolution BCVA 1 month after injection, CMT1 central macular thickness 1 day before injection, CMT2 central macular thickness 1 week after injection, CMT3 central macular thickness 1 month after injection, OD right eye, OS left eye

ISSN: 1756-0500